期刊文献+

老年患者感染泛耐药肺炎克雷伯菌的用药分析

Analysis of the Carbapenem-resistant on Elderly Patients with Klebsiella Pneumoniae Infection
下载PDF
导出
摘要 目的:探讨老年患者感染耐碳青霉烯类肺炎克雷伯菌感染的治疗方案。方法:通过临床药师参与,协助临床医生为患者制定个体化给药方案,给予替加环素联合阿米卡星抗感染治疗,并监护用药过程。结果:治疗方案有效,未出现不良反应,患者病情好转出院。结论:临床药师参与临床治疗可促进用药合理化,保证老年患者用药安全。 Objective To investigation the treatment of carbapenem-resistant Klebsiella pneumoniae in elderly patients. Methods: Clinical pharmacists assisted clinicians in formulating individual drug delivery schemes for patients with tegocycline combined with amikacin anti-infection treatment, and monitoring the process of drug use. Results: The treatment is effective, there is no adverse reaction and the patient is well discharged from the hospital. Conclusion: Clinical pharmacists participating in clinical treatment promotes the rational use of drugs, and ensures drug safety in the elderly.
作者 李娟 艾美玲 吴婷 LI Juan;AI Mei-ling;WU Ting(Department of Pharmacy,third affiliated Hospital of Nanchang University,Nanchang Jiangxi 330008,China;Department of Respiratory,third affiliated Hospital of Nanchang University,Nanchang Jiangxi 330008,China)
出处 《药品评价》 CAS 2018年第22期61-64,共4页 Drug Evaluation
关键词 临床药师 耐碳青霉烯类肺炎克雷伯菌 用药监护 Clinical Pharmacist Carbapenem-resistant Klebsiella Pneumoniae Medication Monitoring
  • 相关文献

参考文献3

二级参考文献24

  • 1陈钟英,临床药物手册(第3版),1995年,38页
  • 2汪复,抗菌药物临床应用新编,1994年,69页
  • 3竺心影,药理学(第3版),1994年,69页
  • 4Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram negative bacilli: need for international harmonization in terminology[J]. Clin Infect Dis, 2008, 46(7): 1121-1122.
  • 5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty fourth informational supplement, 2014, M100-S24.
  • 6Hu F, Chen S, Xu X, et al. Emergence of carbapenem- resistant Enterobacteriaceae clinical isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012, 61 (Pt 1): 132-136.
  • 7Van Duin D, Kaye KS, Neuner EA, et al. Carbapenem-resistant Enterol2acteriaceae= a review of treatment and outcomes [J]. Diagn Microbiol Infect Dis, 2013, 75(2): 115-120.
  • 8Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase- producing Klebsiella tmeumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems[J]. Antimicrob Agents Chemother, 2014, 58 (4): 2322-2328.
  • 9Tascini C, Jagliaferri E, Giani T, et al. Synergistic activity of colistin plus rifampin against colistin resistant KPC producing Klebsiella pneumoniae [J]. Antimicrob Agents Chemother, 2013, 57(8): 3990-3993.
  • 10Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions [J]. Clin Microbiol Rev, 2012, 25(4): 682-707.

共引文献1013

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部